Literature DB >> 21168123

Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis.

Andrew M McIntosh1, David C Owens, William J Moorhead, Heather C Whalley, Andrew C Stanfield, Jeremy Hall, Eve C Johnstone, Stephen M Lawrie.   

Abstract

BACKGROUND: Structural differences between the brains of people with schizophrenia and control subjects are highly replicated but the timing and clinical correlates are unclear. In the Edinburgh High Risk Study, we have followed up 162 individuals at high genetic risk of schizophrenia and 36 healthy control subjects over 10 years.
METHODS: Participants received detailed clinical and up to five structural magnetic resonance imaging (MRI) assessments at 2-year intervals. All 436 MRI scans acquired were parcellated and adjusted for between-scanner differences. The trajectory of any structural MRI changes was then investigated using mixed effects analysis of variance.
RESULTS: Seventeen of the 146 high-risk subjects who were scanned developed schizophrenia over the 8 years of the study. People at high genetic risk of schizophrenia had significantly greater reductions over time than the control group for whole brain volume and left and right prefrontal and temporal lobes. Greater prefrontal reductions were shown in high-risk subjects who subsequently became unwell compared with those who did not. These changes were significantly associated with increasing severity of psychotic symptoms.
CONCLUSIONS: Individuals at high genetic risk of schizophrenia exhibited reductions in cerebral volume that were not found in control subjects. Changes in brain structure were also associated with increasing psychotic symptom severity as people developed schizophrenia. The progressive reductions found in those who went on to develop schizophrenia suggest an additional brain insult near to the time of onset.
Copyright © 2011 Society of Biological Psychiatry. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21168123     DOI: 10.1016/j.biopsych.2010.11.003

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  38 in total

1.  Early prodromal symptoms can predict future psychosis in familial high-risk youth.

Authors:  Neeraj Tandon; Debra Montrose; Jai Shah; R P Rajarethinam; Vaibhav A Diwadkar; Matcheri S Keshavan
Journal:  J Psychiatr Res       Date:  2011-11-04       Impact factor: 4.791

2.  What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?

Authors:  Christoph U Correll; Jose M Rubio; John M Kane
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

Review 3.  Brain imaging during the transition from psychosis prodrome to schizophrenia.

Authors:  Yoonho Chung; Tyrone D Cannon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

4.  The Puzzle of Neuroimaging and Psychiatric Diagnosis: Technology and Nosology in an Evolving Discipline.

Authors:  Martha J Farah; Seth J Gillihan
Journal:  AJOB Neurosci       Date:  2012-10-08

Review 5.  Gray matter alterations in schizophrenia high-risk youth and early-onset schizophrenia: a review of structural MRI findings.

Authors:  Benjamin K Brent; Heidi W Thermenos; Matcheri S Keshavan; Larry J Seidman
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2013-07-23

6.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

Review 7.  Brain Biomarkers of Vulnerability and Progression to Psychosis.

Authors:  Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

8.  Clinical, Cognitive, and Neuroimaging Evidence of a Neurodevelopmental Continuum in Offspring of Probands With Schizophrenia and Bipolar Disorder.

Authors:  Gisela Sugranyes; Elena de la Serna; Roger Borras; Vanessa Sanchez-Gistau; Jose C Pariente; Soledad Romero; Inmaculada Baeza; Covadonga M Díaz-Caneja; Elisa Rodriguez-Toscano; Carmen Moreno; Miguel Bernardo; Dolores Moreno; Eduard Vieta; Josefina Castro-Fornieles
Journal:  Schizophr Bull       Date:  2017-10-21       Impact factor: 9.306

9.  Predicting first episode psychosis in those at high risk for genetic or cognitive reasons.

Authors:  Stephen M Lawrie; Andrew Stanfield; Eve C Johnstone; Andrew M McIntosh
Journal:  Epidemiol Psychiatr Sci       Date:  2012-09-12       Impact factor: 6.892

10.  Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk.

Authors:  Tyrone D Cannon; Yoonho Chung; George He; Daqiang Sun; Aron Jacobson; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Clark Jeffries; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen
Journal:  Biol Psychiatry       Date:  2014-06-12       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.